EA201001481A1 - Производные третичного амина в качестве ингибиторов фосфодиэстеразы-4 - Google Patents

Производные третичного амина в качестве ингибиторов фосфодиэстеразы-4

Info

Publication number
EA201001481A1
EA201001481A1 EA201001481A EA201001481A EA201001481A1 EA 201001481 A1 EA201001481 A1 EA 201001481A1 EA 201001481 A EA201001481 A EA 201001481A EA 201001481 A EA201001481 A EA 201001481A EA 201001481 A1 EA201001481 A1 EA 201001481A1
Authority
EA
Eurasian Patent Office
Prior art keywords
inhibitors
phosphodiesterase
derivatives
tertiary amine
compounds
Prior art date
Application number
EA201001481A
Other languages
English (en)
Other versions
EA018069B1 (ru
Inventor
Андреа Рицци
Элисабетта Армани
Илария Перетто
Элена Ла Порта
Original Assignee
КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. filed Critical КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А.
Publication of EA201001481A1 publication Critical patent/EA201001481A1/ru
Publication of EA018069B1 publication Critical patent/EA018069B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

Изобретение относится к ингибиторам (I) фермента фосфодиэстеразы 4 (PDE4). Более конкретно, изобретение относится к соединениям, которые представляют собой третичные амины, способам получения таких соединений, содержащим их композициям и их терапевтическому применению.
EA201001481A 2008-04-14 2009-03-27 Производные третичного амина в качестве ингибиторов фосфодиэстеразы-4 EA018069B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08007284A EP2110375A1 (en) 2008-04-14 2008-04-14 Phosphodiesterase-4 inhibitors belonging to the tertiary amine class
PCT/EP2009/002242 WO2009127320A1 (en) 2008-04-14 2009-03-27 Tertiary amine derivatives as phosphodiesterase-4 inhibitors

Publications (2)

Publication Number Publication Date
EA201001481A1 true EA201001481A1 (ru) 2011-06-30
EA018069B1 EA018069B1 (ru) 2013-05-30

Family

ID=39731427

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201001481A EA018069B1 (ru) 2008-04-14 2009-03-27 Производные третичного амина в качестве ингибиторов фосфодиэстеразы-4

Country Status (13)

Country Link
US (1) US7820698B2 (ru)
EP (2) EP2110375A1 (ru)
JP (1) JP5492190B2 (ru)
KR (1) KR101208193B1 (ru)
CN (1) CN102007117B (ru)
AU (1) AU2009238014B2 (ru)
BR (1) BRPI0907267A2 (ru)
CA (1) CA2721240A1 (ru)
EA (1) EA018069B1 (ru)
HK (1) HK1155450A1 (ru)
MX (1) MX2010011016A (ru)
WO (1) WO2009127320A1 (ru)
ZA (1) ZA201007317B (ru)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2022783A1 (en) 2007-08-08 2009-02-11 CHIESI FARMACEUTICI S.p.A. "Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors"
EP2216327A1 (en) 2009-02-06 2010-08-11 CHIESI FARMACEUTICI S.p.A. Benzoic acid (1-phenyl-2-pyridin-4-yl)ethyl esters as phosphodiesterase inhibitors
BR112013002504A2 (pt) 2010-08-03 2016-05-31 Chiesi Farma Spa formulação farmacêutica para administração em aerosol, inalador pressurizado dosimetrado (pmdi), formulação farmacêutica para nebulização, frasco de dose única ou múltiplas e uso de uma formulação
AU2012266514A1 (en) 2011-06-06 2014-01-09 Chiesi Farmaceutici S.P.A. Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
CN103827088B (zh) 2011-09-26 2017-10-13 奇斯药制品公司 作为磷酸二酯酶抑制剂的1‑苯基‑2‑吡啶基烷基醇的衍生物
CA2875421A1 (en) * 2012-06-04 2013-12-12 Chiesi Farmaceutici S.P.A. Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
EP2928880B1 (en) 2012-12-05 2018-02-14 Chiesi Farmaceutici S.p.A. Phenylethylpyridine derivatives as pde4-inhibitors and muscarinic receptor antagonists
RU2015121037A (ru) 2012-12-05 2017-01-11 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Производные фенилэтилпиридина в качестве ингибиторов pde-4
CA2893649A1 (en) 2012-12-05 2014-06-12 Chiesi Farmaceutici S.P.A. Phenylethylpyridine derivatives as pde4-inhibitors
EP2928869B1 (en) 2012-12-05 2019-02-20 Chiesi Farmaceutici S.p.A. 1-phenyl-2-pyridinyl alkyl alcohol derivatives as phosphodiesterase inhibitors
US9427376B2 (en) 2013-10-10 2016-08-30 Chiesi Farmaceutici S.P.A. Process for preparing pharmaceutical formulations for inhalation comprising a high-dosage strength active ingredient
WO2017089347A1 (en) 2015-11-25 2017-06-01 Inserm (Institut National De La Sante Et De La Recherche Medicale) Methods and pharmaceutical compositions for the treatment of braf inhibitor resistant melanomas

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU57603A (sh) * 2001-01-22 2006-08-17 Memory Pharmaceuticals Corporation Inhibitori fosfodiesteraze 4
CA2492907A1 (en) * 2002-07-19 2004-01-29 Memory Pharmaceuticals Corporation Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs
WO2004046113A2 (en) * 2002-11-19 2004-06-03 Memory Pharmaceuticals Corporation Pyridine n-oxide compounds as phosphodiesterase 4 inhibitors
EP1443330A1 (en) * 2003-02-03 2004-08-04 Gilson Sas Methods, rack and device for preparing samples for analysis
MY141255A (en) * 2003-12-11 2010-03-31 Memory Pharm Corp Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs
WO2006135828A2 (en) 2005-06-10 2006-12-21 Memory Pharmaceuticals Corporation Trisubstituted amines as phosphodiesterase 4 inhibitors
ATE496029T1 (de) * 2006-07-14 2011-02-15 Chiesi Farma Spa Derivate von 1-phenyl-2-pyridinylalkylenalkohole als phosphodiesteraseinhibitoren
DK2049556T3 (da) * 2006-08-09 2013-08-12 Basilea Pharmaceutica Ag Nye makrolider anvendelige mod inflammatoriske og allergiske sygdomme

Also Published As

Publication number Publication date
CN102007117A (zh) 2011-04-06
BRPI0907267A2 (pt) 2015-07-21
AU2009238014B2 (en) 2013-07-18
AU2009238014A1 (en) 2009-10-22
MX2010011016A (es) 2010-11-09
US7820698B2 (en) 2010-10-26
EA018069B1 (ru) 2013-05-30
KR20100128330A (ko) 2010-12-07
CA2721240A1 (en) 2009-10-22
US20090258905A1 (en) 2009-10-15
CN102007117B (zh) 2014-06-25
EP2268632B1 (en) 2012-08-08
KR101208193B1 (ko) 2012-12-04
ZA201007317B (en) 2012-01-25
HK1155450A1 (en) 2012-05-18
EP2110375A1 (en) 2009-10-21
EP2268632A1 (en) 2011-01-05
JP2011517687A (ja) 2011-06-16
WO2009127320A1 (en) 2009-10-22
JP5492190B2 (ja) 2014-05-14

Similar Documents

Publication Publication Date Title
EA201001481A1 (ru) Производные третичного амина в качестве ингибиторов фосфодиэстеразы-4
EA201000149A1 (ru) Производные 1-фенил-2-пиридинилалкиловых спиртов в качестве ингибиторов фосфодиэстераз
EA200970156A1 (ru) Пиридизиноновые производные
EA201070247A1 (ru) Ингибиторы протеасом
EA200701252A1 (ru) Гетероароматические соединения хинолинов и их применение в качестве ингибиторов pde10
NO20093009L (no) Kondensert ring heterocykel kinase modulatorer
EA201000642A1 (ru) 2'-фтор-2'-дезокситетрагидроуридины в качестве ингибиторов цитидиндеаминазы
EA201100311A1 (ru) Амидные производные гетероарилов и их применение в качестве активаторов глюкокиназы
EA201200323A1 (ru) Соединения и композиции, как ингибиторы протеинкиназы
UA83875C2 (ru) Производные хинолина для применения в качестве микобактериальных ингибиторов
EA201170508A1 (ru) Производные 1-амино-2-циклобутилэтилбороновой кислоты
EA200900983A1 (ru) Соединения и композиции в качестве ингибиторов киназы
MA32508B1 (fr) Composes organiques
GEP20135785B (en) Pyrrolopyrimidine compounds as cdk inhibitors
HRP20070043A2 (en) Antiviral compounds
EA201000100A1 (ru) Гетероциклические соединения, полезные в качестве ингибиторов mk2
EA200971051A1 (ru) Ингибиторы p70 s6 киназы
MXPA06011327A (es) Azaindoles utiles como inhibidores de jak y otras proteinas cinasas.
EA201100749A1 (ru) Производные пиридина и пиримидина в качестве ингибиторов фосфодиэстеразы 10
EA201170531A1 (ru) Соединения на основе пиридина и пиримидина в качестве ингибиторов сигнального пути wnt для лечения рака
SG195319A1 (en) Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
EA201500182A1 (ru) 4-МЕТИЛ-2,3,5,9,9b-ПЕНТААЗАЦИКЛОПЕНТА[a]НАФТАЛИНЫ
EA201071224A1 (ru) Ингибиторы limk2, композиции, содержащие их, и способы их применения
MX2008001538A (es) Aril piridinas y metodos para su uso.
EA200970349A1 (ru) Ингибиторы металлопротеазы гетероциклического происхождения

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU